Companies / INCY vs CRL
INCY vs CRL: Incyte and Charles River Laboratories International
Incyte (INCY) reported $5.1B in revenue against a 25.0% net margin, while Charles River Laboratories International (CRL) reported $4.0B at a -3.6% net margin, most recently.
| Metric | INCY | CRL |
|---|---|---|
| Revenue | $5.1B | $4.0B |
| Net Income | $1.3B | $-0.1B |
| Gross Margin | 92.8% | — |
| Operating Margin | 29.5% | 0.6% |
| EPS (Diluted) | $6.41 | $-2.91 |
| Free Cash Flow | — | $0.5B |
| Total Debt | — | $2.1B |
| P/E Ratio | 15.4× | n/m |
| P/B Ratio | 3.8× | 3.2× |
| Stock Price | $119.99 | $312.87 |
Free: last 5 years
| Fiscal year | FY2009 🔒 | FY2010 🔒 | FY2011 🔒 | FY2012 🔒 | FY2013 🔒 | FY2014 🔒 | FY2015 🔒 | FY2016 🔒 | FY2017 🔒 | FY2018 🔒 | FY2019 🔒 | FY2020 🔒 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| INCY Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $3.0B | $3.4B | $3.7B | $4.2B | $5.1B |
| CRL Revenue | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | ••••• | $3.5B | $4.0B | $4.1B | $4.0B | $4.0B |